HF
ATRS

HRT Financial’s Antares Pharma, Inc. ATRS Stock Holding History

HRT Financial’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-79,484
Closed -$346K – 3959
2021
Q2 		$346K Buy
+79,484
New +$324K ﹤0.01% 2057
2020
Q4 		– Sell
-118,784
Closed -$320K – 2713
2020
Q3 		$320K Buy
+118,784
New +$329K 0.01% 1105
2020
Q1 		– Sell
-23,884
Closed -$112K – 1512
2019
Q4 		$112K Sell
23,884
-18,678
-44% -$76.4K ﹤0.01% 1019
2019
Q3 		$142K Buy
+42,562
New +$140K 0.01% 1208

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

HRT Financial's ATRS Position: Q3 2021 in Review

HRT Financial sold out of Antares Pharma, Inc. (ATRS) in Q3 2021, closing a stake of 79,484 shares — an estimated $346K sold.

HRT Financial first reported a position in ATRS in Q3 2019 and held it in 4 quarters. The position peaked at $346K in Q2 2021. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

  • HRT Financial reported no remaining Antares Pharma, Inc. position as of Q3 2021 after selling out during the quarter.
  • HRT Financial sold 79,484 Antares Pharma, Inc. shares in Q3 2021, an estimated $346K.
  • HRT Financial first reported a position in Antares Pharma, Inc. in Q3 2019 and held it in 4 quarters.
  • HRT Financial's Antares Pharma, Inc. position peaked at $346K in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on HRT Financial's 13F filing for Q3 2021, filed 15 Nov 2021.